SEARCH RESULTS FOR: "Tag: XBI"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(1)
2019(3)
2018(4)
2017(12)
2016(3)
2015(1)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(3)
Best and Worst Stocks(4)
By the Numbers(1)
Editor's Pick(2)
Expectational Analysis(1)
Indexes and ETFs(15)
Intraday Option Activity(9)
Quantitative Analysis(7)
Stock Market News(3)
Stocks On the Move(1)
Technical Analysis(2)
Unusual Trading Activity(1)

5/4/2020 1:46 PM
As summer inches closer, the classic mantra "sell in May and go away" is always worth revisiting. But instead of focusing on the stocks that struggle, we took a look at the best sectors to own during ...
5/26/2019 8:34 AM
The following is a reprint of the market commentary from the June 2019 edition of The Option Advisor, published on May 24. For more information, or to subscribe to The Option Advisor -- featuring 10...
3/4/2019 9:44 AM
The technical breakout last week in the SPDR S&P Biotech ETF (XBI) was remarkable, by any number of measures. After a 3% opening gap to start Monday's session, the small-cap biotech-focused exchange-...
1/23/2019 2:46 PM
It's turning out to be a down day for drug stocks, as the SPDR S&P Biotech ETF (XBI) trades down 1.8% at $79.43. In the meantime, one options trader is putting their money behind a three-way bearish ...
7/17/2018 7:34 AM
As we head into July options expiration week, there's no shortage of catalysts -- both micro and macro -- to drive major stock market moves. Not only are we heading into the thick of second-quarter ea...
 
Special Offers from Schaeffer's Trading Partners